Download full-text PDF

Source
http://dx.doi.org/10.1177/01945998211027354DOI Listing

Publication Analysis

Top Keywords

response "nonopioid
4
"nonopioid combination
4
combination formulations"
4
response
1
combination
1
formulations"
1

Similar Publications

Background: In recent years, the Netherlands has experienced a notable increase in opioid prescriptions and associated fatalities. Emergency department (ED) patients exhibit relatively high rates of opioid use (15%) and misuse (23% of patients who present to the ED and use prescription opioids test positive for misuse). To mitigate opioid-related harm, the American College of Emergency Physicians (ACEP) advocates for the use of non-opioid analgesics and minimal opioid prescriptions.

View Article and Find Full Text PDF

Objective: To evaluate opioid consumption for 21 procedures over 4 years from the Michigan Surgical Quality Collaborative (MSQC) registry and update post-discharge prescribing guidelines.

Background: Opioids remain a common treatment for postoperative pain of moderate-to-severe intensity not adequately addressed by nonopioid analgesics, but excessive prescribing correlates with increased usage. This analysis provides updates and compares patient-reported consumption in response to new guidelines.

View Article and Find Full Text PDF

Introduction: Self-medication (SM) with non-opioid analgesics (NOAs) has become increasingly prevalent, with individuals using over-the-counter medications to manage pain and other symptoms without professional guidance. While NOAs are generally considered safe when used appropriately, misuse or overuse can lead to adverse effects, including gastrointestinal issues, liver damage, and renal problems.

Aim: This study aimed to evaluate the knowledge, awareness, and attitudes regarding NOAs and their SM practices, including how these factors vary by demographic characteristics.

View Article and Find Full Text PDF

Pleasant subjective effects of drugs (e.g., euphoria) have been demonstrated to contribute to their abuse potential.

View Article and Find Full Text PDF

Anti-tumor activity of butorphanol in colorectal cancer via targeting SIGMAR1.

Discov Oncol

November 2024

Department of Surgical Anesthesiology, Zhongshan Hospital Xiamen University, School of Medicine, Xiamen University, No. 201-209, Hubinnan Road, Siming District, Xiamen, 361000, Fujian, China.

Colorectal cancer (CRC) stands for a prevailing gastrointestinal neoplasm, concomitant with considerable occurrence and lethality rate. Butorphanol, a synthetic opioid analgesic medication targeting the opiate receptor, has been recently reckoned to harbor anti-oncogenic properties. This study proposes to delineate the impacts of butorphanol on CRC and the interrelated response mechanism.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!